000			03831nam a2200301 4500
001			390230
010			_a9789291684137
090			_a390230
100			_a20110415d2010 y0pory50 ba
101			_aeng
200			_aGuidelines for collecting data on retail drug prices in Europe _bRecurso eletrónico _eissues and challenges _fEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
210			_aLuxembourg _cPublications Office of the European Union _d2010
215			_a1 CD-ROM _d12 cm
225			_aEMCDDA Manuals _v5
300			_aFicheiro de 1,54 Mb em formato pdf (138 p.). Também disponível em: https://www.emcdda.europa.eu/attachements.cfm/att_101278_EN_EMCDDA-Manual5_Retail%20prices.pdf.Acedido a 15 de Abril de 2011.
330			_aAcknowledgements. Preface. Chapter 1: Introduction. Why collect data on (retail) drug prices? European and other international data collection systems on drug prices. Methods of collecting retail drug prices data in Europe and beyond. Why the present guidelines? Chapter 2: General data collection issues. Definition — retail drug prices. Sampling retail drug prices. Geographical coverage. Sampling over time. Factors influencing retail price observations. Determinants of drug markets. Characteristics of the retail drug markets. Products and purchases. Variables to record for each transaction. Legal issues related to data collection. Chapter 3: Principal methods of data collection in Europe. Overview of the principal methods currently in use in Europe. Covert drug purchases (by law enforcement agencies): test purchases. Objectives. Details of the method. Strengths and weaknesses. An example — National Covert Drug Purchase Database, United Kingdom. Informants run by law enforcement agencies. Objectives. Details of the method. Strengths and weaknesses. Interrogation of arrestees. Objectives. Details of the method. Strengths and weaknesses. Overt drug purchases (purchases by non-law enforcement agents). Objectives. Details of the method. Strengths and weaknesses. An example — SINTES information system, France. Surveys of drug users. Objectives. Details of the method. Strengths and weaknesses. An example — Survey ENa-CAARUD, France. An example — The Oslo study, Norway. An example — The Antenna monitoring scheme, The Netherlands. Interviews with key experts. Objectives. Details of the method. Strengths and weaknesses. An example — Project TREND, France. An example — Central Bureau of Investigation survey, Poland. Other methods. Eavesdropping. Documentation seized by law enforcement agencies. General population surveys. Ethnographic observation. Chapter 4: General data management, reporting and analysis issues. Study protocol. Products. Selecting transactions from the retail market. Dealing with non-standardised units. Data cleaning and construction of the data matrix. Construction of the data matrix. Validation procedures. Standard descriptive measures. Reporting — from local to national. Analysis at national level. Feedback to data providers. Publication. Cross-country comparative analysis. Glossary. Bibliography. Annexes. Annex 1: EMCDDA Standard Table. Annex 2: Metropolitan Police Service covert drug purchase database form. Annex 3: Notice 10-06 item 2 of the Metropolitan Police Service. Annex 4: Statistics and indicators: examples of calculation.
606			_aGUIA DE INFORMAÇÃO _91233
606			_aTRÁFICO DE DROGA _9238858
606			_aROTA DE DROGA _9343871
606			_aRECOLHA DA PROVA _9322094
606			_aANÁLISE DA INFORMAÇÃO _9343238
606			_aANÁLISE CRIMINAL _9321724
606			_aEUROPA _9326972
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta